Abstract
After a very slow start, the clinical application of MRS is now beginning to expand. This expansion is in part related to the increased availability in hospital environments of suitable high-field imaging spectrometers with bores up to whole-body diameter. Other factors are also involved. Although the modality has been shown to be effective in certain specialized fields, the more general usefulness of MRS in health care has only recently become apparent. With the primitive methods of signal localization available using a surface coil alone, investigations were initially limited to superficial tissues (e.g., skeletal muscle) and a few special situations. Clinical users of MRS now have a selection of effective localization methods, which show great promise and can be applied to studies with many different nuclei (see Chapter 5). These techniques permit the selection of a volume of interest from a series of 1H magnetic resonance images obtained from contiguous slices and the collection of spectroscopic data only from tissue within that selected volume. The power of these noninvasive biochemical assay methods is greatly enhanced by the fact that, in many tissues, magnetic susceptibility changes are small. This allows much better homogeneity of the field within the volume of interest and hence improved spectroscopic resolution.1 As a result, it is becoming evident that 1H and other nuclei will have a role in the future which will be as important as that of the 31P nucleus. In addition, localization techniques are now available which allow some degree of flexibility not only in the position and size of the sensitive volume but also in its orientation and shape.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cox, I. J., Bryant, D. J., Ross, B. D., etal.: Spectral resolution in clinical magnetic resonance spectroscopy, Magn. Resort. Med. 5: 186–190, 1987.
Radda, G. K.: The use of NMR spectroscopy for the understanding of disease, Science 233: 640–645, 1986.
Chance, B., Eleff, S., and Leigh, J. S.: Noninvasive, nondestructive approaches to cell bioenergetics, Proc. Natl. Acad. Sci. USA 77: 7430–7434, 1980.
Ross, B. D., Radda, G. K., Gadian, D. G., et al.: Examination of a case of suspected McArdle’s syndrome by 31P nuclear magnetic resonance, N. Engl. J. Med. 304: 1338–1342, 1981.
Chance, B., Eleff, S., Leigh, J. S., et al.: Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle. A gated 31P NMR study, Proc. Natl. Acad. Sci. USA 78: 6714–6718, 1981.
Gadian, D. G., Radda, G. K., Ross, B. D., etal.: Examination of a myopathy by phosphorus nuclear magnetic resonance, Lancet 2: 774–775, 1981.
Cady, E. B., Costello, A. M,. de L., Dawson, M. J. et al.: Non-invasive investigation of cerebral metabolism in newborn infants by phosphorus nuclear magnetic resonance spectroscopy, Lancet 1: 1059–1062, 1983.
Bottomley, P. A., Hart, H. R., Edelstein, W. A., etal.: NMR imaging/speetroscopy system to study both anatomy and metabolism, Lancet 2: 273–274, 1983.
Pape, K. E. and Wigglesworth, J. S.: Haemmorhage, Ischaemia and the Perinatal Brain, London, Heinemann (Spastics International Medical Publications ), 1979.
Volpe, J. J.: Neurology of the newborn, Philadelphia, Saunders, 1987.
Younkin, D. P., Delivoria-Papadopolous, M., Leonard, J., etal.: Unique aspects of human newborn cerebral metabolism evaluated with 31-P NMR spectroscopy, Ann. Neurol 16: 581–586, 1984.
Hope, P. L., Costello, A. M. de L., Cady, E. B., etal.: Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants, Lancet 2: 366–370, 1984.
Veech, R. L., Harris, R. L., Veloso, D., et al.: Freeze-blowing: A new technique for the study of brain in vivo, J. Neurochem. 20: 183–188, 1973.
Duffy, T. E., Kohle, S. J., and Vannucci, R. C.: Carbohydrate and energy metabolism in perinatal rat brain: Relation to survival in anoxia, J. Neurochem. 24: 271–276, 1975.
Vannucci, R. C. and Vannucci, S. J.: Cerebral carbohydrate metabolism during hypoglycemia and anoxia in newborn rats, Ann. Neurol. 4: 73–79, 1978.
Chapman, A. G., Westerberg, E., and Siesjo, B. K.: The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery, J. Neurochem. 36: 179–189, 1981.
Glonek, T., Kopp, S. J., Kot, E., etal.: P-31 nuclear magnetic resonance analysis of brain: The perchloric acid extract spectrum, J. Neurochem. 39: 1210–1219, 1982.
Gyulai, L., Bolinger, L., Leigh, J. S., et al: Phosphorylethanolamine—the major constituent of the phosphomonoester peak observed by 31P-NMR on developing dog brain, FEBS Lett. 178: 137–142, 1984.
Brenton, D. P., Garrod, P. J., Krywawych, S., etal.: Phosphoethanolamine is major constituent of phosphomonoester peak detected by 31P NMR in newborn brain, Lancet 1: 115, 1985.
Pettegrew, J. W., Kopp, S. J., Dadok, J., et al.: Chemical characterization of a prominent phosphomonoester resonance from mammalian brain. 31P and 1H NMR analysis at 4.7 and 14.1 tesla, J. Mag. Res. 67: 443–450, 1986.
Agrawal, H. C. and Himwich, W. A.: Amino acids, proteins and monoamines of developing brain, in Himwich, W. A. (ed.): Developmental Neurobiology, Springfield, 111., C. C. Thomas, 1970, p. 298.
Okumura, N., Otsuki, S., and Kameyama, A.: Studies on free amino acids in human brain, J. Biochem. (Tokyo) 47: 315–320, 1960.
Chapman, A. G., Westerberg, E., and Siesjo, B. K.: The metabolism of purine and pyrimidine nucleotides in rat cortex during insulin-induced hypoglycemia and recovery, J. Neurochem. 36: 179–189, 1981.
Gonzalez-Mendez, R., Litt, L., Koretsky, A. P., et al.: Comparison of 31P NMR spectra of in vivo rat brain using convolution difference and saturation with a surface coil. Source of the broad component in the brain spectrum, J. Mag. Res. 57: 526–533, 1984.
Stubbs, M., Vanstapel, F., Rodrigues, L. M., et al.: Phosphate metabolites in rat skin, NMR in Biomedicine 1: 50–55, 1988.
Pettegrew, J. W., Minshew, N. J., Diehl, J., et al.: Anatomical considerations for interpreting topical 31P-NMR, Lancet 2: 913, 1983.
Tofts, P. S., Cady, E. B., Delpy, D. T., et al.: Surface coil NMR spectroscopy of brain, Lancet 1: 459, 1984.
Evelhoch, J. L., Crowley, M. G., and Ackerman, J. J. H.: Signal-to-noise optimization and observed volume localization with surface coils, J. Mag. Res. 56: 110–124, 1984.
Bottomley, P. A., Hart, H. R., Edelstein, W. A., et al: Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 tesla, Radiology 150: 441–446, 1984.
Bottomley, P. A., Foster, T. B., and Darrow, R. D.: Depth-resolved surface-coil spectroscopy (DRESS) for in vivo 1H, 31P, and 13C NMR, J. Mag. Res. 59: 338–342, 1984.
Bottomley, P. A., Edelstein, W. A., Hart, H. R., et al: Spatial localization in 31P and 13C NMR spectroscopy in vivo using surface coils, Magn. Resort. Med. 1: 410–413, 1984.
Brindle, K. M., Smith, M. B., Rajagopalan, B., etal.: Spectral editing in 31P NMR spectra of human brain, J. Mag. Res. 61: 559–563, 1985.
Ng, T. C., Majors, A. W., and Meany, T. F.: In vivo MR spectroscopy of human subjects with a 1.4-T whole body MR imager, Radiology 158: 517–520, 1986.
Oberhaensli, R. D., Galloway, G. J., Hilton-Jones, D., et al.: The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy, Br. J. Radiol. 60: 367–373, 1987.
Bailes, D. R., Bryant, D. J., Bydder, G. M., etal: Localized phosphorus-31 NMR spectroscopy of normal and pathological human organs in vivo using phase encoded techniques, J. Mag. Res. 74: 158–170, 1987.
Tofts, P. S. and Wray, S.: Changes in brain phosphorus metabolites during the post-natal development of the rat, J. Physiol. (London) 359: 417–429, 1985.
Reynolds, E. O. R., Wyatt, J. S., Azzopardi, D., etal.: New non-invasive methods for assessing brain oxygenation and haemodynamics, Br. Med. Bull. 44: 1052–1075, 1988.
Azzopardi, D., Wyatt, J. S., and Hamilton, P. A.: Phosphorus metabolites and intracellular pH in the brains of normal and small-for-gestational age infants investigated by magnetic resonance spectroscopy, Pediatr. Res. 25: 440–444, 1989.
Minton, S. D., Steichen, J. J., and Tsang, R. C.: Bone mineral content in term and preterm appropriate-for-gestational age infants, J. Pediatr. 95: 1037–1042, 1979.
Dobbing, J. and Sands, J.: Quantitative growth and development of human brain, Arch. Dis. Child. 48: 757–767, 1973.
Lawson, B., Anday, E., Guillet, R., etal.: Brain oxidative phosphorylation following alteration in head position in preterm and term neonates, Pedatr. Res. 22: 302–305, 1987.
Cady, E. B.: Absolute quantitation of phosphorus metabolites in the cerebral cortex of the newborn human infant and in the forearm muscles of young adults using a double tuned surface coil, J. Mag. Res. (in press), 1990.
Thulborn, K. R. and Ackerman, J. J. H.: Absolute molar concentrations by NMR in inhomogeneous Bl. A scheme for analysis of in vivo metabolites, J. Mag. Res. 55: 357–371, 1983.
Cohen, M. M. and Lin, S.: Acid soluble phosphates in the developing rabbit brain, J. Neurochem. 9: 345–352, 1962.
Cerdan, S., Subramanian, V. H., Hilberman, M., etal.: 31P NMR detection of mobile dog brain phospholipids, Magn. Reson. Med. 3: 432–439, 1986.
Delpy, D. T., Cope, M. C., Cady, E. B., et al.: Cerebral monitoring in newborn infants by magnetic resonance and near infrared spectroscopy, Scandinavian Journal of Clinical Laboratory Investigation 47 (Suppl. 188): 9–17, 1987.
Hamilton, P. A., Hope, P. L., Cady, E. B., et al.: Impaired energy metabolism in brains of newborn infants with increased cerebral echodensities, Lancet 1: 1242–1246, 1986.
Azzopardi, D., Wyatt, J. S., Cady, E. B., etal.: Prognosis of newborn infants with hypoxic-ischaemic brain injury assessed by phosphorus magnetic resonance spectroscopy, Pediatr. Res. 25: 445–451, 1989.
Griffiths, R.: The Abilities of Babies. London, University of London Press, 1954.
Bottomley, P. A., Smith, L. S., Leue, W. M., etal.: Slice-interleaved depth-resolved surface-coil spectroscopy (SLIT DRESS) for rapid 31P NMR in vivo, J. Mag. Res. 64: 347–351, 1985.
Bottomley, P. A., Drayer, B. P., and Smith, L. S.: Chronic adult cerebral infarction studied by phosphorus NMR spectroscopy, Radiology 160: 763–766, 1986.
Gordon, R. E., Hanley, P. E., Shaw, D., et al.: Localization of metabolites in animals using 31P topical magnetic resonance, Nature 287: 736–738, 1980.
Gordon, R. E., Hanley, P. E., and Shaw, D.: Topical magnetic resonance, Progress in Nuclear Magnetic Resonance Spectroscopy 15: 1–47, 1982.
Bottomley, P. A. and Hardy, C. J.: PROGRESS in efficient three-dimensional spatially localized in vivo 31P NMR spectroscopy using multidimensional spatially selective (p) pulses, J. Mag. Res. 74: 550–556, 1987.
Ordidge, R. J., Connelly, A., and Lohman, J. A. B.: Image selected in-vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy, J. Mag. Res. 66: 283–294, 1986.
Segebarth, C. M., Baleriaux, D. F., Arnold, D. L., et al.: MR image-guided P-31 MR spectroscopy in the evaluation of brain tumor treatment, Radiology 165: 215–219, 1987.
Silver, M. S., Joseph, R. I., Chen, C-N., et al.: Selective population inversion in NMR, Nature 310: 681–683, 1984.
Bottomley, P. A., Charles, H. C., Roemer, P. B., et al.: Human in vivo phosphate metabolite imaging with 31P NMR, Magn. Reson. Med. 7: 319–336, 1988.
Hardy, C. J., Bottomley, P. A., Roemer, P. B., et al.: Rapid 31P spectroscopy on a 4-T whole-body system, Magn. Reson. Med. 8: 104–109, 1988.
Lenkinski, R. E., Holland, G. A., Allman, T., et al.: Integrated MR imaging and spectroscopy with chemical shift imaging of P-31 at 1.5 T: Initial experience, Radiology 169: 201–206, 1988.
Tropp, J. S., Sugiura, S., Derby, K. A., et al.: Characterization of MR spectroscopic imaging of the human head and limb at 2.0 T, Radiology 169: 207–212, 1988.
Bottomley, P. A. and Hardy, C. J.: Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance, Clin. Chem. 35: 392–395, 1989.
Roth, K., Hubesch, B., Meyerhoff, D. J., et al.: Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopy, J. Mag. Res. 81: 299–311, 1989.
Kwee, I. L. and Nakada, T.: Phospholipid profile of the human brain: 31P NMR spectroscopic study, Magn. Reson. Med. 6: 296–299, 1988.
Bottomley, P. A., Edelstein, W. A., Foster, T. H., et al: In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: A window to metabolism? Proc. Natl. Acad. Sci. USA 82: 2148–2152, 1985.
Luyten, P. R. and den Hollander, J. A.: Observation of metabolites in the human brain by MR spectroscopy, Radiology 161: 795–798, 1986.
Hore, P. J.: Solvent suppression in Fourier transform nuclear magnetic resonance, J. Mag. Res. 55: 283–300, 1983.
Luyten, P. R., Marien, A. D. H., Sijtsma, B., et al.: Solvent-suppressed spatially resolved spectroscopy. An approach to high-resolution NMR on a whole body MR system, J. Mag. Res. 67: 148–155, 1986.
Barany, M., Langer, B. G., Glick, R. P., et al.: In vivo H-l spectroscopy in humans at 1.5 T, Radiology 167: 839–844, 1988.
Bendall, M. R. and Gordon, R. E.: Depth and refocusing pulses designed for multipulse NMR with surface coils, J. Mag. Res. 53: 365–385, 1983.
Hanstock, C. C., Rothman, D. L., Jue, T., et al.: Volume-selected proton spectroscopy in the human brain, J. Mag. Res. 77: 583–588, 1988.
Bodenhausen, G., Freeman, R., and Turner, D. L.: Suppression of artifacts in two-dimensional J spectroscopy, J. Mag. Res. 27: 511–514, 1977.
Morris, G. A. and Freeman, R.: Selective excitation in Fourier transform nuclear magnetic resonance, J. Mag. Res. 29: 433–462, 1978.
Hanstock, C. C., Rothman, D. L., Prichard, J. W., et al.: Spatially localized 1H NMR spectra of metabolites in the human brain, Proc. Natl. Acad. Sci. USA 85: 1821–1825, 1988.
Rothman, D. L., Hanstock, C. C., Ogino, T., et al.: Edited 1H human brain spectra of amino acids at 2.1 T, Proceedings, seventh Annual Meeting, Society for Magnetic Resonance in Medicine, San Francisco, 1988, p. 254.
Hanstock, C., Rothman, D., Shulman, R., et al.: Ethanol observed in human brain by proton magnetic resonance spectroscopy, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 1071.
Frahm, J., Bruhn, H., Gyngell, M. L., etal.: Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo, Magn. Reson. Med. 9: 79–93, 1989.
Bruhn, H., Frahm, J., Gyngell, M. L., etal.: Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy, Magn. Reson. Med. 9: 126–131, 1989.
Edwards, R. H. T., Dawson, M. J., Wilkie, D. R., et al.: Clinical use of nuclear magnetic resonance in the investigation of myopathy, Lancet 1: 725–731, 1982.
Wilkie, D. R., Dawson, M. J., Edwards, R. H. T., et al.: 31P NMR studies of resting muscle in normal human subjects, in Pollack, G. H. and Sugi, H. (eds.): Contractile Mechanisms in Muscle, New York, Plenum Press, 1984, p. 333.
Radda, G. K., Bore, P. J., and Rajagopalan, B.: Clinical aspects of 31P NMR spectroscopy, Br. Med. Bull. 40: 155–159, 1984.
Edwards, R. H. T., Griffiths, R. D., and Cady, E. B.: Topical magnetic resonance for the study of muscle metabolism in human myopathy, Clin. Physiol. 5: 93–109, 1985.
Kushmerick, M. J., McFarland, E. W., Conley, K. E., et al.: Characterization of fiber types in normal human muscle by 31P-NMR spectroscopy, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 462.
Aldridge, R., Cady, E. B., Jones, D. A., et al.: Muscle pain after exercise is linked with an inorganic phosphate increase as shown by 31P NMR, Biosci. Rep. 6: 663–667, 1986.
Thomsen, C., Jensen, K. E., Henriksen, O., etal.: Glucose induced thermogenesis in human skeletal muscle studies by 31P MR-spectroscopy, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 302.
Dawson, M. J.: Quantitative analysis of metabolite levels in normal human subjects by 31P topical magnetic resonance, Biosci. Rep. 2: 727–733, 1982.
Newman, R. J., Bore, P. J., Chan, L., etal.: Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy, Br. Med. J. 284: 1072–1074, 1982.
Griffiths, R. D., Cady, E. B., Edwards, R. H. T., etal.: Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: Controlled trials show no effect of allopurinol or ribose, Muscle and Nerve 8: 760–767, 1985.
Younkin, D. P., Berman, P., Sladky, J., et al.: 31P NMR studies in Duchenne muscular dystrophy: Age-related metabolic changes, Neurology 37: 165–169, 1987.
Hands, L. J., Bore, P. J., Galloway, G., etal.: Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy, Clin. Sci. 71: 283–290, 1986.
Wilson, J. R., Fink, L., Maris, J., etal.: Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance, Circulation 71: 57–62, 1985.
Frostick, S. P., Taylor, D. J., Yonge, R. P., et al.: A study of muscle denervation using phosphorus-31 magnetic resonance spectroscopy. Proceedings, fifth Annual Meeting, Society of Magnetic Resonance in Medicine, Works in Progress, Montreal, 1986, p. 69.
Zochodne, D. W., Thompson, R. T., Driedger, A. A., et al.: Metabolic changes in human muscle denervation: Topical 31P NMR spectroscopy studies, Magn. Reson. Med. 7: 373–383, 1988.
Taylor, D. J., Bore, P. J., Styles, P., et al.: Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study, Molecular Biology in Medicine 1: 77–94, 1983.
Arnold, D. L., Matthews, P. M., and Radda, G. K.: Metabolic recovery after exercise and the assessment of mitochondrial function in vivo in human skeletal muscle by means of 31P NMR, Magn. Reson. Med. 1: 307–315, 1984.
Taylor, D. J., Styles, P., Matthews, P. M., et al.: Energetics of human muscle: Exercise-induced ATP depletion, Magn. Reson. Med. 3: 44–54, 1986.
Taylor, D. J., Crowe, M., Bore, P. J., etal.: Examination of the energetics of aging skeletal muscle using nuclear magnetic resonance, Gerontology 30: 2–7, 1984.
Rees, D., Smith, M. B., Harley, J., et al.: In vivo functioning of creatine phosphokinase in human forearm muscle, studied by 31P NMR saturation transfer, Magn. Reson. Med. 9: 39–52, 1989.
Dawson, M. J., Gadian, D. G., and Wilkie, D. R.: Muscular fatigue investigated by phosphorus nuclear magnetic resonance, Nature 274: 861–866, 1978.
Miller, R. G., Giannini, D., Milner-Brown, H. S., et al.: Effects of fatiguing exercise on high-energy phosphates, force, and EMG: Evidence for 3 phases of recovery, Muscle Nerve 10: 810–821, 1987.
Miller, R. G., Boska, M. D., Moussavi, R. S., et al.: 31P nuclear magnetic resonance studies of high energy phosphates and pH in human muscle fatigue, J. Clin. Invest. 81: 1190–1196, 1988.
Cady, E. B., Jones, D. A., Lynn, J., et al.: Changes in force and intracellular metabolites during fatigue of human skeletal muscle, J. Physiol. (London) 418: 311–325, 1989.
Wilson, J. R., McCully, K. K., Mancini, D. M., et al.: Relationship of muscular fatigue to pH and diprotonated Pi in humans: A 31P-NMR study, Journal of Applied Physiology 64: 2333–2339, 1988.
Wilkie, D. R.: Muscular fatigue: Effects of hydrogen ions and inorganic phosphate, Federal Proceedings 45: 2921–2923, 1986.
Nosek, T. M., Fender, K. Y., and Godt, R. E.: It is diprotonated inorganic phosphate that depresses force in skinned skeletal muscle fibers, Science 236: 191–193, 1987.
Cady, E. B., Eishove, H., Moll, A., et al.: The metabolic causes of slow relaxation in fatigued human skeletal muscle, J. Physiol. (London) 418: 327–337, 1989.
Chance, B., Eleff, S., Bank, W., et al.: 31P NMR studies of control of mitochondrial function in phosphofructokinase-deflcient human skeletal muscle, Proc. Natl. Acad. Sci. USA 79: 7714–7718, 1982.
Arnold, D. L., Bore, P. J., Radda, G. K., et al.: Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome, Lancet 1: 1367–1369, 1984.
Wilson, J. R., Fink, L., Maris, J., etal.: Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance, Circulation 71: 57–62, 1985.
Hands, L. J., Bore, P. J., Galloway, G., etal: Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy, Clin. Sci. 71: 283–290, 1986.
Frahm, J., Merboldt, K., and Hanicke, W.: Localized proton spectroscopy using stimulated echoes, J. Mag. Res. 72: 502–508, 1987.
Narayana, P. A., Jackson, E. F., Hazle, J. D., etal.: In vivo localized proton spectroscopic studies of human gastrocnemius muscle, Magn. Reson. Med. 8: 151–159, 1988.
Pan, J. W., Hamm, J. R., Hetherington, H. P., etal.: Quantitation of lactate in human muscle by 1H NMR, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 106.
Pan, J. W., Hamm, J. R., Rothman, D. L., etal.: Intracellular pH of human muscle by 1H NMR, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 251.
Barany, M., Doyle, D. D., Graff, G., etal.: Natural abundance 13C NMR spectra of human muscle, normal and diseased, Magn. Reson. Med. 1: 30–43, 1984.
Avison, M. J., Rothman, D. L., Nadel, E., et al.: Detection of human muscle glycogen by natural abundance 13C NMR, Proc. Natl. Acad. Set USA 85: 1634–1636, 1988.
Pillai, R. P., Buescher, P. C., Pearse, D. B., etal.: 31P NMR spectroscopy of isolated perfused lungs, Magn. Reson. Med. 3: 467–472, 1986.
Bottomley, P. A.: Noninvasive study of high-energy phosphate metabolism in human heart by depth-resolved 31P NMR spectroscopy, Science 229: 769–772, 1985.
Bottomley, P. A., Herfkens, R. J., Smith, L. S., etal.: Altered phosphate metabolism, in myocardial infarction: P-31 MR spectroscopy, Radiology 165: 703–707, 1987.
Blackledge, M. J., Rajagopalan, B., Oberhaensli, R. D., etal.: Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR, Proc. Natl. Acad. Sci. USA 84: 4283–4287, 1987.
Radda, G. K.: The use of NMR spectroscopy for the understanding of disease, Science 233: 640–645, 1986.
Styles, P., Scott, C. A., and Radda, G. K.: A method for localizing high-resolution NMR spectra from human subjects, Magn. Reson. Med. 2: 402–409, 1985.
Matson, G. B., Twieg, D. B., Karczmar, G. S., et al.: Application of image-guided surface coil P-31 spectroscopy to human liver, heart and kidney, Radiology 169: 541–547, 1988.
Jue, T., Rothman, D. L., Lohman, J. A. B., et al.: Surface coil localization of 31P NMR signals from orthotopic human kidney and liver, Proc. Natl. Acad. Sci. USA 85: 971–974, 1988.
Maris, J. M., Evans, A. E., McLaughlin, A. C., et al.: 31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ, N. Engl. J. Med. 312: 1500–1505, 1985.
Oberhaensli, R. D., Galloway, G. J., Taylor, D. J., etal.: Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy, Br. J. Radiol. 59: 695–699, 1986.
Oberhaensli, R. D., Hilton-Jones, D., Bore, P., etal.: Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy, Lancet 2: 8–11, 1986.
Oberhaensli, R. D., Rajagopalan, B., Taylor, D. J., et al: Study of hereditary fructose intolerance by use of 31P magnetic resonance spectroscopy, Lancet 2: 931–934, 1987.
Sauter, R., Mueller, S., and Weber, H.: Localization in in vivo 31P NMR spectroscopy by combining surface coils and slice-selective saturation, J. Mag. Res. 75: 167–173, 1987.
Segebarth, C., Luyten, P. R., and den Hollander, A.: Improved depth-selective single surface-coil 31P NMR spectroscopy using a combination of Bi and B0 selection techniques, J. Mag. Res. 75: 345–351, 1987.
Cox, I. J., Bryant, D. J., Collins, A. G., etal.: Four-dimensional chemical shift MR imaging of phosphorus metabolites of normal and diseased human liver, J. Comput. Assist. Tomogr. 12: 369–376, 1988.
Cox, I. J., Sargentoni, J., Calam, J., etal.: Four-dimensional phosphorus-31 chemicalshift imaging of carcinoid metastases in the liver, NMR in Biomedicine 1: 56–60, 1988.
Jue, T., Lohman, J. A. B., Ordidge, R. J., et al.: Natural abundance 13C NMR spectrum of glycogen in humans, Magn. Reson. Med. 5: 377–379, 1987.
Ross, B., Marshall, V., Smith, M., etal.: Monitoring response to chemotherapy of intact human tumours by 31P nuclear magnetic resonance, Lancet 1: 641–646, 1984.
Chew, W. M., Hricak, H., and McClure, R. D.: In vivo human testicular function assessed by 31P MRS, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 322.
Achten, E., Van Cauteren, M., Wisanto, A., etal.: Phosphorus-31 magnetic resonance spectroscopy of the human testicle: Normal values and a case of varicocele, Proceedings, seventh Annual Meeting, Society of Magnetic Resonance in Medicine, San Francisco, 1988, p. 58 (works in progress).
Iles, R. A., Hind, A. J., and Chalmers, R. A.: Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias, Clin. Chem. 31: 1795–1801, 1985.
Iles, R. A., Chalmers, R. A., and Hind, A. J.: Methylmalonic aciduria and propionic acidemia studied by proton nuclear magnetic resonance spectroscopy, Clin. Chim. Acta 173: 173–189, 1986.
Yamaguchi, S., Koda, N., Eto, Y., et al.: Rapid screening of metabolic disease by proton NMR urinalysis, Lancet 2: 284, 1984.
Bales, J. R., Higham, D. P., Howe, I., et al.: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine, Clin. Chem. 30: 426–432, 1984.
Bales, J. R., Sadler, P. J., Nicholson, J. K., et al.: Urinary excretion of acetaminophen and its metabolites as studied by proton NMR spectroscopy, Clin. Chem. 30: 1631–1636, 1984.
Bales, J. R., Nicholson, J. K., and Sadler, P. J.: Two-dimensional proton nuclear magnetic resonance “maps” of acetaminophen metabolites in human urine, Clin. Chem. 31: 757–762, 1985.
Bales, J. R., Bell, J. D., Nicholson, J. K., et al.: Metabolic profiling of body fluids by proton NMR: Self poisoning episodes with paracetamol (acetaminophen), Magn. Reson. Med. 6: 300–306, 1988.
Gillies, R. J., Powell, D. A., Nelson, T. R., etal.: High resolution proton NMR spectroscopy of human amniotic fluid, Proceedings, fourth Annual Meeting, Society of Magnetic Resonance in Medicine, London, 1985, p. 789.
Bell, J. D., Sadler, P. J., Macleod, A. F., et al.: 1H NMR studies of human blood plasma, FEBS Lett. 219: 239–243, 1987.
Bell, J. D., Brown, J. C. C., Kubal, G., et al.: NMR-invisible lactate in blood plasma, FEBS Lett. 235: 81–86, 1988.
Fossel, E. T., Carr, J. M., and McDonagh, J.: Detection of malignant tumors: Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma, N. Engl. J. Med. 315: 1369–1376, 1986.
Bell, J. D., Brown, J. C. C., Norman, R. E., et al.: Factors affecting 1H NMR spectra of blood plasma: Cancer, diet and freezing, NMR in Biomedicine 1: 90–94, 1988.
Holmes, K. T., Mackinnon, W. B., May, G. L., et al.: Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer, NMR in Biomedicine 1: 44–49, 1989.
Eskelinen, S., Hiltunen, Y., Jokisarri, J., et al.: 1H NMR studies on human plasma lipids from newborn infants, healthy adults, and adults with tumors, Magn. Reson. Med. 9: 35–38, 1989.
Moon, R. B. and Richards, J. H.: Determination of intracellular pH by 31P magnetic resonance, J. Biol Chem. 248: 7276–7278, 1973.
Henderson, T. O., Costello, A. J. R., and Omachi, A.: Phosphate metabolism in intact human erythrocytes: Determination by phosphorus31 nuclear magnetic resonance spectroscopy, Proc. Natl Acad. Sci. USA 71: 2487–2490, 1974.
Costello, A. J., Marshall, W. E., Omachi, A., et al.: Interactions between hemoglobin and organic phosphates investigated with 31P nuclear magnetic resonance spectroscopy and ultrafiltration, Biochim. Biophys. Acta 427: 481–491, 1976.
Gupta, R. K., Benovic, J. L., and Rose, Z. B.: The determination of the free-magnesium level in the human red blood cell by 31P NMR, J. Biol Chem. 253: 6172–6176, 1978.
Tehrani, A. Y., Lam, Y. F., Lin, A. K., et al.: Phosphorus-31 nuclear magnetic resonance studies of human red blood cells, Blood Cells 8: 245–261, 1982.
Zwerling, H. K., Diamond, J. N., Levy, G. C., et al.: Phosphorus-31 nuclear magnetic resonance measurements of 2,3-DPG degradation in human adult and cord blood erythrocytes, Magn. Reson. Med. 3: 10–14, 1986.
Brown, F. F., Campbell, I. D., Kuchel, P. W., etal.: Human erythrocyte metabolism studies by 1H spin echo NMR, FEBS Lett. 82: 12–16, 1977.
Yeh, J. C., Brindley, F. J., and Becker, E. D.: Nuclear magnetic resonance studies on intra-cellular sodium in human erythrocytes and frog muscle, Biophys. J. 13: 56–71, 1973.
Gupta, R. K. and Gupta, P.: Direct observation of resolved resonances from intra- and extracellular sodium-23 ions in NMR studies of intact cells and tissues using dysprosium(III)tripolyphosphate as paramagnetic shift reagent, J. Mag. Res. 47: 344–350, 1982.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Cady, E.B. (1990). Clinical Studies. In: Clinical Magnetic Resonance Spectroscopy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1333-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1333-5_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1335-9
Online ISBN: 978-1-4684-1333-5
eBook Packages: Springer Book Archive